West Midlands HealthTech/MedTech ‘6D’ Innovation Accelerator

西米德兰兹健康科技/医疗科技 – 6D – 创新加速器

• 批准号: 10056871
• 金额: $ 1849.3万
• 依托单位: UNIVERSITY OF BIRMINGHAM
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10056871
• 关键词: West; Midlands; HealthTech; MedTech; 6D

The Healthcare Technology and Medical Technology sectors are currently worth £17billion per annum to the UK, and with the ageing population and poor health following the pandemic, are projected to grow to £21billion per annum by 2027\. However, the relatively high levels of regulation in these sectors, can make it slow and expensive for new companies to bring their technologies to the UK market, something that has hindered growth comparative to other global competitors.The West Midlands '6D' Innovation Accelerator (6D-IA) will unite key players across the region (universities, hospitals, industry and government-funded 'Catapults' for manufacturing innovation) to address these problems by creating a supportive environment to accelerate new technologies towards commercialisation. The partners will run a centrally coordinated series of activities that will help companies to navigate "pinch-points" in the process of medical translation. Our '6Ds' include diagnosis of company needs; definition of NHS or corporate challenges to respond to; development and refinement of prototype products or services; deployment of innovation in real-world NHS settings; diversification of cross-sectoral collaborations; and demonstration of economic benefit for our interventions.Together, this will create a cluster of commercial activity in this sector, helping to drive regional economic growth and enhance resilience. It will also ensure that local patients will benefit first from new medical technologies targeted at reducing significant regional healthcare inequalities. The 6D-IA will also provide a national focus for the development and deployment of new healthcare technologies, growing a vibrant and self-sustaining cluster of activity centred in the new Precision Healthcare Technology Accelerator, leveraging major recent private investment alongside significant regional assets to attract and support medical innovators.The 6D-IA will place the West Midlands at the forefront of UK medical innovation by supercharging a cluster of activity in the Greater Birmingham area with strong regional and national links. It will boost economic activity within the region, attracting up to £80-100million in additional private investment by 2026/27\. It will also facilitate the transformation of the delivery of healthcare by creating a strong focus on the development of new digitally-enabled innovations, providing strong secondary care proof-of-principle with associated pilot work in community and primary care.

目前，英国的医疗保健技术和医疗技术行业每年价值 170 亿英镑，随着人口老龄化和大流行后健康状况不佳，预计到 2027 年将增长到每年 210 亿英镑。这些行业的监管可能会使新公司将其技术引入英国市场的速度缓慢且成本高昂，这阻碍了与其他全球竞争对手相比的增长。 西米德兰兹“6D”创新加速器(6D-IA) 将联合该地区的主要参与者（大学、医院、工业界和政府资助的制造创新“弹射器”），通过创造支持性环境来加速新技术商业化来解决这些问题。合作伙伴将集中运营一个项目。协调一系列活动，帮助公司应对医疗翻译过程中的“关键点”；我们的“6D”包括诊断公司需求；定义 NHS 或应对原型产品或服务的开发和完善； ;在现实世界的 NHS 环境中部署创新；跨部门合作的多样化；以及展示我们的干预措施的经济效益。这将在该领域创建一个商业活动集群，有助于推动区域经济增长并增强复原力。它还将确保当地患者首先受益于旨在减少重大区域医疗保健不平等的新医疗技术。6D-IA 还将为新医疗保健技术的开发和部署提供全国重点，从而发展一个充满活力和自我维持的集群。以活动为中心的在新的精准医疗技术加速器中，利用近期的主要私人投资以及重要的区域资产来吸引和支持医疗创新者。6D-IA 将通过增强大伯明翰的一系列活动，使西米德兰兹郡处于英国医疗创新的前沿它将促进该地区的经济活动，到 2026/27 年吸引高达 80-1 亿英镑的额外私人投资\。重点关注新的数字化创新的开发，提供强有力的二级护理原理验证以及社区和初级护理的相关试点工作。